We are proud to share our latest results on the professional equality index, reflecting our commitment to fostering an inclusive and equitable workplace:
- Pay gap: 38/40
- Raises gap: 20/20
- Promotions gap: 15/15
- Return from maternity leave: 15/15
- 10 highest salaries: 0/10
Gender Equality Index for 2024
Score 88/100
The professional Equality Index helps companies to promote women in employment, to maintain equal treatment and to progress in their access to decision-making bodies. (1)
The Gender Equality index score for the European Union is 71 out of 100 points. This marks an incremental 0.8-point improvement on the 2023 index score and an increase of 7.9 points in total since 2010. Convergence analysis shows that gender equality disparities within the EU decreased between 2010 and 2022. (2)
France scores 76.1 out of 100, i.e. an increase of 0.4 point compared to 2023. France ranks 6th in the EU, stable since 2023. (2)
Novalix’s scores demonstrate our ongoing efforts to promote women in employment, ensure equal treatment, and enhance women’s access to decision-making roles.
Advancing Gender Equality in the pharmaceutical sector
The pharmaceutical industry plays a crucial role not only in advancing healthcare but also in setting standards for workplace equality. Despite significant progress, challenges persist, particularly at leadership levels.
Recent data indicates that while women constitute a substantial portion of the pharmaceutical workforce, their representation diminishes at higher echelons of leadership. For instance:
- Overall Workforce: Women make up approximately 46% of the pharmaceutical workforce in Europe, a higher proportion than in many other key industries. (3)***
- Leadership Roles: Women hold about 28% of executive roles in the pharmaceutical industry, reflecting an increase from 21% in 2018. (4)
- Executive Teams: In 2021, women comprised 28% of executive teams at the top 20 pharmaceutical firms, marking a 35% increase from 2018. (4)
- Top Salaries: Women occupied 44.7% of the top-paying jobs in the pharmaceutical industry, while they held 64.8% of the lowest-paid positions. (4)
These figures underscore the ongoing need for strategic initiatives to promote gender parity, especially in leadership roles. At Novalix, we are dedicated to bridging these gaps. We believe that empowering women in the workplace enhances innovation, drives growth, and fosters a culture of inclusivity. Our commitment is not just about meeting regulatory requirements but about leading by example and creating a workplace where everyone has equal opportunities to succeed.
Together, we can inspire change and build a more equitable future for all.
Sources:
(1) https://egapro.travail.gouv.fr/
(2) https://eige.europa.eu/gender-equality-index/2024/FR
(3) efpia.eu
(4) pharmexec.com